<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="tnfr1_7s" dataset_id="pht000175.v7" study_name="Framingham Cohort" study_id="phs000007.v30" participant_set="11" date_created="2018/09/17"><description>Tumor Necrosis Factor Receptor II, Offspring Cohort Exam 7</description><variable id="phv00023914.v6.p11" var_name="shareid" calculated_type="string" reported_type=""><description>UNIQUE PARTICIPANT ID</description><total><subject_profile><sex><male>1478</male><female>1717</female></sex></subject_profile><stats><stat n="3195" nulls="0"/></stats></total></variable><variable id="phv00023914.v6.p11.c1" var_name="shareid" calculated_type="string" reported_type=""><description>UNIQUE PARTICIPANT ID</description><total><subject_profile><sex><male>1188</male><female>1395</female></sex></subject_profile><stats><stat n="2583" nulls="0"/></stats></total></variable><variable id="phv00023914.v6.p11.c2" var_name="shareid" calculated_type="string" reported_type=""><description>UNIQUE PARTICIPANT ID</description><total><subject_profile><sex><male>288</male><female>318</female></sex></subject_profile><stats><stat n="606" nulls="0"/></stats></total></variable><variable id="phv00023912.v6.p11" var_name="IDTYPE" calculated_type="enum_integer" reported_type=""><description>COHORT IDENTIFIER</description><total><subject_profile><sex><male>1478</male><female>1717</female></sex></subject_profile><stats><stat n="3195" nulls="0" mean_count="3195" median_count="3195" min_count="3195" max_count="3195"/><enum code="1" count="3195">OFFSPRING GROUP</enum></stats></total></variable><variable id="phv00023912.v6.p11.c1" var_name="IDTYPE" calculated_type="enum_integer" reported_type=""><description>COHORT IDENTIFIER</description><total><subject_profile><sex><male>1188</male><female>1395</female></sex></subject_profile><stats><stat n="2583" nulls="0" mean_count="2583" median_count="2583" min_count="2583" max_count="2583"/><enum code="1" count="2583">OFFSPRING GROUP</enum></stats></total></variable><variable id="phv00023912.v6.p11.c2" var_name="IDTYPE" calculated_type="enum_integer" reported_type=""><description>COHORT IDENTIFIER</description><total><subject_profile><sex><male>288</male><female>318</female></sex></subject_profile><stats><stat n="606" nulls="0" mean_count="606" median_count="606" min_count="606" max_count="606"/><enum code="1" count="606">OFFSPRING GROUP</enum></stats></total></variable><variable id="phv00023913.v6.p11" var_name="tnfr2" calculated_type="decimal" units="PG/ML" reported_type=""><description>TUMOR NECROSIS FACTOR RECEPTOR II FROM PLASMA (PG/ML)</description><total><subject_profile><sex><male>1478</male><female>1717</female></sex></subject_profile><stats><stat n="3195" nulls="0" mean="2153" sd="793.7" median="1977" min="671.2" max="8383"/><example count="2">2167.95</example><example count="2">1691.90</example><example count="2">2790.80</example><example count="2">3212.97</example><example count="2">1819.05</example><example count="2">1836.51</example><example count="2">1896.48</example><example count="2">2062.63</example><example count="2">1858.74</example><example count="2">1772.31</example></stats></total></variable><variable id="phv00023913.v6.p11.c1" var_name="tnfr2" calculated_type="decimal" units="PG/ML" reported_type=""><description>TUMOR NECROSIS FACTOR RECEPTOR II FROM PLASMA (PG/ML)</description><total><subject_profile><sex><male>1188</male><female>1395</female></sex></subject_profile><stats><stat n="2583" nulls="0" mean="2075" sd="670" median="1945" min="671.2" max="8383"/><example count="2">2167.95</example><example count="2">1691.90</example><example count="2">2790.80</example><example count="2">3212.97</example><example count="2">1819.05</example><example count="2">2062.63</example><example count="2">1858.74</example><example count="2">1772.31</example><example count="2">1701.80</example><example count="2">2221.72</example></stats></total></variable><variable id="phv00023913.v6.p11.c2" var_name="tnfr2" calculated_type="decimal" units="PG/ML" reported_type=""><description>TUMOR NECROSIS FACTOR RECEPTOR II FROM PLASMA (PG/ML)</description><total><subject_profile><sex><male>288</male><female>318</female></sex></subject_profile><stats><stat n="606" nulls="0" mean="2485" sd="1127" median="2176" min="916.5" max="8215"/><example count="2">1983.89</example><example count="1">5549.24</example><example count="1">2500.65</example><example count="1">2851.83</example><example count="1">4458.43</example><example count="1">2927.72</example><example count="1">3333.73</example><example count="1">1683.18</example><example count="1">2155.96</example><example count="1">2094.13</example></stats></total></variable></data_table>
